DCAT Value Chain Insights

COVID-19's Impact on Global Pharma Supply Chains

In the wake of COVID-19, industry groups, including the Pharmaceutical Research and Manufacturers of America and the Association of Accessible Medicines, are raising concerns over reduced...

The Race for a Vaccine Against the Novel Coronavirus

Johnson & Johnson reported this week that it expects its lead vaccine candidate against the novel coronavirus (COVID-19) to enter clinical trials in September and outlined a manufacturing plan....

Q&A with Stephan Haitz, President, CDMO Sales & Marketing at Cambrex

Information
March 9, 2020
Sponsored by Cambrex

Stephan Haitz, President, CDMO Sales & Marketing discusses small molecule trends and how the CDMO industry is constantly evolving to meet the demands and needs of the growing clinical pipeline.

Read More
A Cambrex Webinar- De-Risking the Solid Form Landscape of an API

Information
February 24, 2020
Sponsored by Cambrex

Dr. David Pearson, Chief Scientific Officer of Cambrex Edinburgh, discusses how a full understanding of the crystalline landscape of an active pharmaceutical ingredient (API) molecule can predict...

Read More
Future focus: Our 2020 vision

Information
February 11, 2020
Sponsored by Cambrex

Cambrex eBook: The pharmaceutical industry continues to grow and is estimated to be worth $1.5 trillion by 2021, driven by positive industry trends — many of which our experts commented on in Part 1...

Read More